July 18, 2011 - New Data Showed Minimal Potential for Drug Interaction between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
Read the full story
Providing Targeted Healthcare Solutions
Kowa Pharmaceuticals America, Inc. (KPA) is a specialty pharmaceutical company located in Montgomery, Alabama focused primarily in the area of cardiometabolic therapeutics. The company, started in 2001 as ProEthic Laboratories LLC., was acquired by Kowa Company, Ltd. (KCL) a privately held multinational company headquartered in Nagoya, Japan in September of 2008. KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products.
